Walleye Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $621K | Buy |
+299,790
| New | +$621K | ﹤0.01% | 998 |
|
|
2023
Q1 | – | Sell |
-845,856
| Closed | -$2.11M | – | 2400 |
|
|
2022
Q4 | $2.11M | Sell |
845,856
-189,226
| -18% | -$473K | 0.04% | 449 |
|
|
2022
Q3 | $4.37M | Buy |
1,035,082
+88,594
| +9% | +$374K | 0.08% | 243 |
|
|
2022
Q2 | $2.64M | Buy |
946,488
+843,014
| +815% | +$2.35M | 0.07% | 282 |
|
|
2022
Q1 | $592K | Buy |
103,474
+54,569
| +112% | +$312K | 0.02% | 895 |
|
|
2021
Q4 | $447K | Buy |
+48,905
| New | +$447K | 0.01% | 1024 |
|